BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8095412)

  • 1. Amplified genes in cancer in upper digestive tract.
    Yoshida T; Sakamoto H; Terada M
    Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological significance of gene amplification in carcinogenesis.
    Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T
    Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
    Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
    Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
    Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
    Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogenes in human gastric carcinoma].
    Tahara E
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL-1 participates in the 11q13 amplification found in breast cancer.
    Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
    Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological significance of the hst-1 gene.
    Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
    Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New molecular prognostic markers in gastric carcinoma].
    Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers].
    Tahara E; Kuniyasu H; Nakayama H; Yasui W; Yokozaki H
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):326-31. PubMed ID: 8094950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and expression of the human cyclin D gene in esophageal cancer.
    Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB
    Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.
    Shiga C; Shiga K; Hirayama K; Katayama M; Nishihira T; Mori S
    Anticancer Res; 1994; 14(2B):651-6. PubMed ID: 8010723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of the hst-1 gene.
    Sugimura T; Yoshida T; Sakamoto H; Katoh O; Hattori Y; Terada M
    Ciba Found Symp; 1990; 150():79-89; discussion 89-98. PubMed ID: 2142645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene].
    Yoshida K; Toge T; Kuniyasu H; Yasui W; Tahara E
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():53-9. PubMed ID: 11424439
    [No Abstract]   [Full Text] [Related]  

  • 20. FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26.
    Katoh M; Katoh M
    Int J Oncol; 2003 May; 22(5):1155-9. PubMed ID: 12684685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.